The best thing about PRR now though is it’s no longer the one trick pony resting all it’s laurels on CVAC and with risk front left right and centre. It now has 4 (soon to be 6) seperate clinical trials running concurrently ! It provides a huge buffer if results are not as good as expected in any of them. Quite ridiculous really that with 6 trials running concurrently the current $60m msrkrt cap only values each at $10m and even then thats ignoring the $12m cash and the real ace card patents, LAG-3, founder and the positioning of it.
massive buy recommendation, page-294
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |